Mira Pharmaceuticals, INC.
SEC CIK 1904286 · MIRA · last insider filing 2026-06-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Macpherson Edward Clouston | Director | filed 2024 - 2026 |
| Shekhat Denil Nanji | Director | filed 2024 - 2026 |
| Del Giudice Matthew Paul | Director | filed 2024 - 2026 |
| Whalen Matthew Pratt | Director | filed 2024 - 2026 |
| Aminov Erez | Director · Chief Executive Officer | filed 2023 - 2026 |
| Jerman Michael Allen | Director | filed 2023 - 2024 |
| Daly Brian Frederick | Director | filed 2023 - 2023 |
| Chapman Christopher C JR | Director · Executive Chairman | filed 2023 - 2023 |
| Nicholoudis Christos | Director | filed 2023 - 2023 |
| Vorhoff David C | Director | filed 2023 - 2023 |
| Mccoll Hugh III | Director | filed 2023 - 2023 |
| Kroenig Bradley | Director | filed 2023 - 2023 |
| Tuck Talhia | Director | filed 2023 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Mushak Andriy | Chief Financial Officer | filed 2026 - 2026 |
| Weichselbaum Alan | Chief Financial Officer | filed 2025 - 2025 |
| Yanez Michelle | Chief Financial Officer | filed 2023 - 2024 |
| Kaplin Adam | Pres. & Chief Scientific Off. | filed 2023 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.